These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 20729233)

  • 41. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD001912. PubMed ID: 25419599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infection, inflammation, and lung function decline in infants with cystic fibrosis.
    Pillarisetti N; Williamson E; Linnane B; Skoric B; Robertson CF; Robinson P; Massie J; Hall GL; Sly P; Stick S; Ranganathan S;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):75-81. PubMed ID: 21493738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD001912. PubMed ID: 23235585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
    Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
    Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
    Lillquist YP; Cho E; Davidson AG
    J Cyst Fibros; 2011 May; 10(3):175-80. PubMed ID: 21310671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
    Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G
    J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.
    Ballmann M; Smyth A; Geller DE
    Respir Med; 2011 Dec; 105 Suppl 2():S2-8. PubMed ID: 22208546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1997 May; 23(5):330-5. PubMed ID: 9168506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre.
    Dijk FN; McKay K; Barzi F; Gaskin KJ; Fitzgerald DA
    Arch Dis Child; 2011 Dec; 96(12):1118-23. PubMed ID: 21994242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylactic antibiotics for cystic fibrosis.
    Smyth A; Walters S
    Cochrane Database Syst Rev; 2003; (3):CD001912. PubMed ID: 12917916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
    Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M
    Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
    Wiesemann HG; Steinkamp G; Ratjen F; Bauernfeind A; Przyklenk B; Döring G; von der Hardt H
    Pediatr Pulmonol; 1998 Feb; 25(2):88-92. PubMed ID: 9516091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.